Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia

NCT01289678 is registered in ClinicalTrials.gov with Leo W. Jenkins Cancer Center as lead sponsor.

NCT NCT01289678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01289678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
Lead sponsor
Leo W. Jenkins Cancer Center
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
August 31, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia